Digital Enterprise Capabilities: Beyond IT with Matt Lasmanis

Biotech Bytes: Conversations with Biotechnology / Pharmaceutical IT Leaders

How do today’s biotech companies cultivate innovation and harness digital tools for strategic growth?
In this episode, we dissect the pivotal role that digital enterprise capabilities play in transforming a company's approach to challenges in the life sciences sector.
As I chat with Matt Lasmanis, Chief Technology & Innovation Officer at Sage Therapeutics, we delve into the transformative power of technology within the biotech industry.
Matt shares his invaluable insights on strengthening a company's data strategy, investing in AI, and integrating advanced analytics to drive informed decisions. We're exploring the notable shift from the traditional IT department to a model that embodies digital and enterprise capabilities, underlining how crucial this evolution is for a company like Sage.
Matt's insights on the cultural shift within the biotech industry and the necessity of a growth mindset promise to be enlightening for leaders and innovators alike.
This episode is a must-listen for anyone looking to understand how strategic digital transformation positions a company at the forefront of innovation. Rediscover the potential within the biotech industry by tuning into our engaging conversation.

Specifically, this episode highlights the following themes:

• The strategic implementation of data analytics and AI within Sage Therapeutics
• Nurturing a culture of innovation within life sciences companies
• The strategic role of cybersecurity and privacy in technology investment decisions

Links from this episode:

• Get to know more about Steven Swan: https://www.linkedin.com/in/swangroup
• Get to know more about Matt Lasmanis: https://www.linkedin.com/in/mattlasmanis
• Learn more about Sage Therapeutics:
  https://www.sagerx.com